je.st
news
Johnson & Johnson edges Street views with weak 2Q
2015-07-14 22:18:25| Biotech - Topix.net
Johnson & Johnson's recovering U.S. consumer health business, following years of recalls that kept Tylenol, Motrin and other marque brands off store shelves, put a much-needed Band-Aid over a rough second quarter. Sales dropped across every other business segment, unusual for the world's top maker of health care products, which also sells prescription medicines and medical devices.
Tags: street
views
johnson
weak
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||